Amantadine Therapy for Cognitive Impairment in Long COVID

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Long COVIDPost-COVID19 ConditionPost-Acute COVID19 Syndrome

Interventions

DRUG

Amantadine

Subjects will be give amantadine 100 mg twice daily.

Trial Locations (1)

RECRUITING

The Ohio State University Medical Center, Columbus

All Listed Sponsors

lead

Ohio State University

OTHER